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Targeting triple-negative breast cancer cells using
Dengue virus-mimicking pH-responsive framboidal
triblock copolymer vesicles†
Charlotte J. Mable,‡*a Irene Canton,‡*b Oleksandr O. Mykhaylyk,a Burcin Ustbas
Gul,§b Pierre Chambon,{a Efrosyni Themistouka and Steven P. Armes ‡*a
It is well-known that the Dengue fever virus undergoes a distinct morphological transition from
topologically smooth particles to ‘bumpy’ particle on increasing the temperature from that of the
mosquito carrier (28 C) to that of the human host (37 C). This virus also possesses pH-sensitive surface
domains that undergo conformational changes during infection which facilitates exit from the
endosomes. Herein we take a bio-inspired approach to design synthetic Dengue virus-mimicking
nanoparticles to target triple-negative (TN) breast cancer cells that overexpress SR-B1 scavenger
receptors. Thus, sterile pH-responsive methacrylic ABC triblock copolymer vesicles were prepared in
aqueous solution via polymerization-induced self-assembly. Microphase separation between two
enthalpically-incompatible hydrophobic membrane-forming blocks produced a well-deﬁned framboidal
morphology, with surface globules of 28 nm diameter protruding from the membrane. The hydrophilic
stabilizer block comprises 97% hydroxyl-functionalized chains and 3% phosphorylcholine-functionalized
chains, with the latter being critical for selective intracellular uptake. These framboidal vesicles remain
intact at neutral pH but become swollen and cationic at pH 5–6 because the tertiary amine residues in
the hydrophobic C block become protonated. We demonstrate that such nanoparticles enable selective
targeting of TN breast cancer cells. This is because such malignant cells overexpress SR-B1 receptors for
naturally-occurring phospholipids and hence take up the phosphorylcholine-decorated framboidal
vesicles preferentially. In contrast, negligible cell uptake is observed over the same time period for both
human dermal ﬁbroblasts and normal breast cancer cells that minimally express the SR-B1 receptor.
Moreover, we show that genetic material within such pH-responsive framboidal vesicles can be
eﬃciently delivered to the cell nuclei while maintaining high cell viability.
Introduction
Viruses have evolved over millions of years to become extremely
eﬀective vectors for eﬃcient intracellular delivery.1 They are
able to target specic mammalian cells, avoid subcellular
barriers and deliver highly sensitive biological molecules such
as proteins and large nucleic acids very eﬃciently.2,3 However,
attempts to use viruses (or viral coats) to treat disease has led to
undesirable side-eﬀects, including patient mortality in some
cases.4 Thus there has been considerable recent interest in the
design of much safer synthetic analogues for viruses.5–8 Two
critical properties that enable viruses to deliver their cargo are
(i) their size and (ii) their ability to change their surface
morphology. The smallest mammalian viruses, such as Parvo-
viridae and Picornaviridae, have particle diameters of approxi-
mately 20–30 nm,9 whereas the largest range from 200 to
400 nm diameter (e.g. the ovoid Poxviridae virus9) and even up
to 540 nm diameter (e.g. Paramixoviruses9,10). Interestingly,
Langer and co-workers recommend that a broad range of length
scales should be considered when designing appropriate drug
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delivery carriers.11 Similarly, Zhao and Stenzel12 recently high-
lighted the importance of nanoparticle size, shape, modulus
and surface charge on the eﬃcacy of intracellular delivery.
In some cases, viral infection is believed to involve stimulus-
responsive behavior. For example, the Dengue fever virus
undergoes a distinct thermally-induced morphological transi-
tion from topologically smooth, pseudo-spherical nanoparticles
of around 50 nm diameter in the mosquito vector at 28 C to
slightly larger, distinctly framboidal nanoparticles in the human
victim at 37 C.13,14 This subtle change in morphology exposes
the DIII domain of the E protein, which participates in receptor
binding.13,14 The complete mechanism of infection for this virus
has not yet been elucidated but the scavenger receptor SR-B1
appears to play an important role.15 Moreover, protruding
nanodomains can induce lipid bilayer deformation, which
should in turn enhance the kinetics of cell uptake.16–18 Indeed,
nanoscale surface roughness is well-known to promote both
protein receptor binding and the intracellular uptake of nano-
particles.19,20 Furthermore, the Dengue fever virus also possesses
pH-sensitive surface domains that undergo conformational
changes during infection which facilitate its timely exit from the
endosomes.21 Such viruses transit through the early endosomes
and fuse with late endocytic organelles at pH 5.5.22 At this lower
local pH, the virus undergoes a further subtle change in its
surface morphology to adopt a more ‘open’ conformation before
its fusion with the endosomal membrane.21–23
Triple-negative (TN) breast cancer has a very poor prognosis
because it is extremely aggressive and lacks targeted therapies.24
TN breast cancer tumors express unusually high levels of SR-B1
and reduced levels of CD-36 receptors.25Moreover, the literature
suggests that the optimal nanoparticle diameter for cell uptake
mediated by scavenger receptors ranges from 20 to 30 nm.26–28
In principle, wholly synthetic Dengue virus-mimicking nano-
particles that exhibit appropriate surface roughness and
stimulus-responsive behavior should enable selective targeting
of TN breast cancer cells.
It is well-known that amphiphilic diblock copolymers
undergo spontaneous self-assembly in aqueous solution.29–32
Moreover, recent advances in polymerization-induced self-
assembly (PISA)33,34 now enable a wide range of block copol-
ymer nanoparticles to be prepared directly in concentrated
aqueous solution via reversible addition–fragmentation chain
transfer (RAFT) aqueous dispersion polymerization.35–37 Of
particular relevance to the present study, a poly(glycerol mon-
omethacrylate) macromolecular chain transfer agent (PGMA
macro-CTA) can be chain-extended using 2-hydroxypropyl
methacrylate (HPMA).37–39 Micellar self-assembly produces
sterically-stabilized PHPMA-core nanoparticles with hydro-
philic PGMA stabilizer chains. Depending on the precise PISA
formulation, a range of copolymer morphologies can be ach-
ieved, including spheres, worms and vesicles.38–40 Furthermore,
RAFT seeded emulsion polymerization has been utilized to
chain-extend PGMA–PHPMA diblock copolymer vesicles using
a water-immiscible monomer (benzyl methacrylate, BzMA).41,42
This leads to microphase separation within the vesicle
membrane, resulting in the formation of PGMA–PHPMA–
PBzMA triblock copolymer vesicles with a distinctive framboidal
morphology. More recently, Mable et al.43 reported the closely-
related synthesis of pH-responsive framboidal vesicles, simply
by using 2-(diisopropylamino)ethyl methacrylate (DPA) instead
of BzMA. Importantly, the mean size of the globules protruding
from the vesicle membrane can be tuned by systematic variation
of the degree of polymerization (DP) of the PDPA block.
Herein we report the design, synthesis and biological eval-
uation of pH-responsive uorescently-labeled framboidal vesi-
cles as a new, wholly synthetic mimic for the Dengue fever virus.
Our approach utilizes the pH-responsive PGMA–PHPMA–PDPA
framboidal vesicles (hereaer denoted as G–H–D for brevity)
previously reported by Mable et al.43 Such nanoparticles can be
prepared via PISA in aqueous solution while replacing a small
fraction (3 mol%) of the PGMA stabilizer chains with a well-
known biocompatible polymer, poly(2-(methacryloyloxy)ethyl
phosphorylcholine) (PMPC).44–49 The pendent phosphorylcho-
line groups on this latter polymer act as a ligand to enable-
targeting of SR-B1 scavenger receptors,50,51 which are
overexpressed by TN breast cancer cells.25,52
Results and discussion
Synthesis and characterization
The framboidal nanoparticles prepared in this work were
synthesized under rigorously sterile conditions. Firstly, PGMA58
and PMPC60 macromolecular chain transfer agents (macro-
CTAs) were each synthesized on a multigram scale. A 97 : 3
binary mixture of these two macro-CTAs (and also a control
comprising 100% PGMA58 macro-CTA) was chain-extended via
RAFT aqueous dispersion copolymerization of a mixture of
HPMA and GlyMA (Fig. 1) under sterile conditions, as described
fully in the ESI.† Briey, 200 nm sterile lters were used to
sterilize all liquid reagents via ultraltration, all glassware was
autoclaved and work was carried out exclusively in a fully-sterile
Class II laminar ow cabinet. The epoxy groups on the GlyMA
units were reacted with rhodamine B piperazine53 using an
epoxy/amine molar ratio of unity to produce uorescently-
labeled diblock copolymer vesicles. Visible absorption spec-
troscopy studies of a dilute methanolic copolymer solution
enabled quantication of the dye conjugation reaction and
indicated that approximately 80% of the epoxy groups had
reacted with the rhodamine B piperazine (see ESI† for further
details).
Aer dialysis to remove excess rhodamine B piperazine,
these precursor nanoparticles were then chain-extended via
RAFT aqueous seeded emulsion polymerization of DPA to
obtain the desired pH-responsive framboidal triblock copol-
ymer vesicles (Fig. 2). Triblock copolymer compositions of
PGMA58–P(HPMA300-stat-GlyMARh1)–PDPA100 and (97 PGMA58
+ 3 PMPC60)–P(HPMA300-stat-GlyMARh1)–PDPA100 were targeted
(see Fig. 1 and 2). For the sake of brevity, these are hereaer
denoted as G58–(H300-stat-ERh1)–D100 and (97 G58 + 3 M60)–
(H300-stat-ERh1)–D100, respectively (where ‘E’ stands for the
reactive epoxy groups within the GlyMA residues).
1HNMR studies indicated that more than 99% conversion of
the HPMA and GlyMA comonomers was achieved within 2 h at
70 C but the nal DPA conversion was only 48% (for vesicles
4812 | Chem. Sci., 2019, 10, 4811–4821 This journal is © The Royal Society of Chemistry 2019
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without PMPC macro-CTA) or 52% (for vesicles with PMPC
macro-CTA) aer 24 h at 70 C (see Fig. S1†).
The latter conversions are relatively low compared to those
reported by Mable et al.43 The only diﬀerence is that the DPA
monomer was lter-sterilized prior to its addition to the reac-
tion ask in the present study. Thus a control experiment was
conducted whereby the mass of DPA monomer was determined
before and aer lter sterilization. This indicated that around
40% of the DPA monomer remained on the lter and therefore
was not in fact added to the reactionmixture. Correcting for this
mass loss of reagent, the DPA conversions are estimated to be
80 and 87% respectively, which is more comparable to those
reported by Mable et al.43 In both cases unreacted DPA mono-
mer was removed from the reaction solution by dialysis, see
ESI.† In summary, the nal diblock copolymer compositions
obtained were G58–(H300-stat-ERh1)–D48 and (97 G58 + 3 M60)–
(H300-stat-ERh1)–D52.
DMF gel permeation chromatography (GPC) studies indi-
cated a low polydispersity (Mw/Mn ¼ 1.13) for the PGMA58
macro-CTA, see Fig. S2a.† Similarly, aqueous GPC data ob-
tained for the PMPC60 macro-CTA also indicated a low poly-
dispersity (Mw/Mn ¼ 1.09, see Fig. S2b†). DMF GPC traces
indicated that both diblock copolymer precursors were ob-
tained with low polydispersities (Mw/Mn < 1.20, see Fig. S2c†).
However, a weak high molecular weight shoulder was
observed, which was attributed to light branching caused by
small amounts of dimethacrylate impurity within the HPMA
monomer (0.07 mol% as judged by HPLC analyses).32 In the
case of the triblock copolymers, the PDPA block is DMF-
insoluble, while the PGMA block is THF-insoluble, rendering
GPC characterization of the triblock copolymers rather prob-
lematic. To render these triblock copolymers THF-soluble for
GPC analysis, the PGMA block was esteried according to
a previously reported protocol (see ESI† for further
details).43,54,55 THF GPC traces obtained for the modied tri-
block copolymers were unimodal and indicated high blocking
eﬃciencies but somewhat broader molecular weight distri-
butions (see Fig. S2d†).
Dynamic light scattering (DLS) studies indicated comparable
hydrodynamic diameters of 344 128 nm and 322 116 nm for
the G58–(H300-stat-ERh1)–D48 and (97 G58 + 3 M60)–(H300-stat-
ERh1)–D52 framboidal vesicles, respectively. Allowing for the
eﬀect of polydispersity, this is consistent with transmission
electron microscopy (TEM) studies, which suggest number-
average vesicle diameters of approximately 300 nm in each
case (Fig. 3). TEM images also conrmed the distinctive fram-
boidal morphology expected for the G58–(H300-stat-ERh1)–D48
and (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 vesicles, with mean
pseudospherical globule diameters (based on analyzing 50
globules averaged over several vesicles) of around 25  6 nm
and 28  8 nm, respectively. Such values should be regarded as
estimates because these surface globules are not as well-dened
as those previously reported by Mable et al.42 This is because the
DP of the globule-forming PDPA block is only 48 or 52 in the
present study, so these surface features are both smaller and
less prominent.
Fig. 1 Synthesis of ﬂuorescently-labelled PGMA58–P(HPMA300-stat-
GlyMARh1) diblock copolymer vesicles (denoted G58–(H300-stat-
ERh1), where m ¼ 100 and n ¼ 0) and (97 PGMA58 + 3 PMPC60)–
P(HPMA300-stat-GlyMARh1) diblock copolymer vesicles (denoted (97
G58 + 3 M60)–(H300-stat-ERh1)–D52 wherem ¼ 97 and n ¼ 3) via RAFT
aqueous dispersion polymerization. Corresponding schematic
cartoons are also shown for each type of precursor vesicle, where
PGMA ¼ red, PMPC ¼ green, P(HPMA-stat-ERh1) ¼ blue. RAFT end-
groups are omitted from chemical structures to aid clarity.
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4811–4821 | 4813
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Fortunately, small-angle X-ray scattering (SAXS) provides
a much more statistically meaningful estimate of the mean
globule diameter.42 SAXS analysis of 1.0% w/w aqueous disper-
sions of (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 enables rigorous
assessment of the copolymer morphologies obtained at various
solution pH. Synchrotron SAXS patterns (Fig. 4a) were collected
at pH 7.4 (red), pH 5.5 (blue) and pH 3.0 (green). A two-
population vesicle plus sphere model is required to t such
SAXS patterns, as reported previously for similar framboidal
vesicles.43 Here, population 1 represents the overall vesicle
morphology while population 2 accounts for the pseudo-
spherical globules protruding from the vesicle membrane, see
the schematic cartoons corresponding to pH 7.4 and pH 5.5
shown in Fig. 4a. A radius of gyration, Rg, of 2.4 nm and
a membrane solvent fraction, xsol, of 0.40 were used as xed
parameters to t these two SAXS patterns.
At pH 7.4, SAXS analysis (Table S1†) indicates that the overall
volume-average vesicle diameter, Dv, is 294 nm, which is
reasonably consistent with the TEM and DLS data (Fig. 3). The
mean core radius of the globules protruding from the fram-
boidal vesicle membrane, Rs, is 9.01  1.7 nm, thus the overall
globule diameter, Ds, was calculated to be 27.6 nm (where Ds ¼
2Rs + 4Rg). This value is consistent with that estimated directly
Fig. 2 Synthetic route used to prepare PGMA58–P(HPMA300-stat-
GlyMARh1)–PDPA48 framboidal vesicles (denoted G58–(H300-stat-
ERh1)–D48, wherem ¼ 100 and n ¼ 0) and (97 PGMA58 + 3 PMPC60)–
P(HPMA300-stat-GlyMARh1)–PDPA52 framboidal vesicles (denoted (97
G58 + 3 M60)–(H300-stat-ERh1)–D52 wherem ¼ 97 and n ¼ 3) via RAFT
aqueous emulsion polymerization. Corresponding schematic
cartoons are also shown for each type of precursor vesicle, where
PGMA ¼ red, PMPC ¼ green, P(HPMA-stat-ERh1) ¼ blue and PDPA ¼
black. RAFT end-groups are omitted from the above chemical struc-
tures to save space and aid clarity.
Fig. 3 Representative TEM images (and corresponding hydrodynamic
diameters and DLS polydispersities) obtained for ﬂuorescently-labeled
(a) smooth G58–(H300-stat-ERh1) diblock copolymer vesicles, (b)
framboidal G58–(H300-stat-ERh1)–D48 triblock copolymer vesicles, (c)
smooth (97 G58 + 3 M60)–(H300-stat-ERh1) diblock copolymer vesicles
and (d) framboidal (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 triblock
copolymer vesicles synthesized at pH 7.4 under sterile conditions.
Corresponding color-coded schematic cartoons are also shown for
each type of vesicle.
4814 | Chem. Sci., 2019, 10, 4811–4821 This journal is © The Royal Society of Chemistry 2019
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from the SAXS pattern, whereby the local minimum at q 
0.226 nm leads to a mean globule diameter, Ds, of 27.7 nm
(calculated using Ds ¼ 2p/q). This is also consistent with the
estimated globule diameter of 28  8 nm from TEM analysis, as
discussed above.
The TEM image obtained for the (97 G58 + 3 M60)–(H300-stat-
ERh1)–D52 triblock copolymer vesicles dried at pH 5.5 (Fig. 4b,
blue-framed image) suggests a similar framboidal morphology
to that observed at pH 7.4. Indeed, DLS studies indicate a Dh of
329  123 nm, which is comparable to that at pH 7.4 (Table 1).
Dv increases by 4% to 305 nm at pH 5.5, which suggests slightly
swollen vesicles. The mean vesicle membrane thickness, Tm, is
reduced by 3% from 22.1  5.0 nm at pH 7.4 to 21.5  5.0 nm at
pH 5.5 (see Table S1†). In addition, the relative proportion of
population 2 (c2/c1) required to achieve a satisfactory t to these
SAXS patterns is reduced from 0.149 at pH 7.4 to 0.137 at pH 5.5,
suggesting less framboidal character at the lower pH. These
observations are consistent with protonation of some of the
tertiary amine groups on the PDPA block, which consequently
becomes less hydrophobic. This reduces the enthalpic incom-
patibility (and hence degree of microphase separation) between
the two hydrophobic blocks, which leads to a discernible
reduction in Rs from 9.01 1.7 nm at pH 7.4 to 8.12 1.6 nm at
pH 5.5 (Table S1,† population 2). Aqueous electrophoresis data
are also consistent with this interpretation: the zeta potential of
the vesicles increases from 2.3 mV at pH 7.4 to +12 mV at pH
5.5 (Table 1). In summary, the TEM images, SAXS analysis and
aqueous electrophoresis data suggest that cationic framboidal
vesicles are formed at pH 5.5 (see inset in Fig. 4b). It is worth
emphasizing that these framboidal vesicles remain intact at pH
5.5. Given that the pKa of the PDPA block is 6.2, this means that
most of the tertiary amine groups are protonated at this pH
which accounts for the appreciable cationic character for these
slightly swollen vesicles. This is comparable to the exit mecha-
nism for the Dengue virus from the endosomes at pH 5.5,
whereby its overall diameter increases by approximately 10%
and a more ‘open’ conformation is adopted.22,23
At pH 3.0, the PDPA blocks should be fully protonated. TEM
analysis indicates that relatively small nano-objects are formed
under these conditions, although it is diﬃcult to assign the
predominant copolymer morphology (Fig. 4c, green-framed
image). DLS studies indicate the presence of nanoparticles
with a sphere-equivalent intensity-average diameter of 39 
16 nm and a count rate of 4400 kcps. The latter is a measure of
the light scattering intensity and should be compared to that of
106 300 kcps observed at pH 7.4 for the original framboidal
vesicles. The SAXS pattern recorded for the aqueous dispersion
of (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 at pH 3.0 diﬀers
markedly from those collected at pH 7.4 and pH 5.5 (Fig. 4d).
The former is relatively featureless, which is consistent with the
anticipated pH-induced disintegration of the original framboi-
dal vesicles to form pseudo-spherical micelles. The slight
upturn in I(q) observed at low q indicates weakly-interacting
particles, which is interpreted in terms of a mass fractal
component.56 Indeed, a reasonably good data t to the SAXS
pattern recorded at pH 3.0 (Fig. 4d) can be achieved by
employing a spherical micelle model (population 2 in Table S1†)
Fig. 4 TEM images obtained for the rhodamine-labeled (97 G58 + 3
M60)–(H300-stat-ERh1)–D52 triblock copolymer nano-objects formed
at (a) pH 7.4, (b) pH 5.5 and (c) pH 3.0. Inset: higher magniﬁcation TEM
images and schematic cartoons representing the copolymer
morphology (PGMA ¼ red, PMPC ¼ green, P(HPMA-stat-ERh1) ¼ blue
and PDPA ¼ black). (d) SAXS patterns obtained for 1.0% w/w aqueous
dispersions of rhodamine-labeled framboidal (97 G58 + 3 M60)–(H300-
stat-ERh1)–D52 triblock copolymer vesicles prepared under sterile
conditions via aqueous PISA at pH 7.4 (red), pH 5.5 (blue) and pH 3.0
(green). Open circles represent experimental data and solid black lines
denote the ﬁts to these X-ray patterns: a two-population ‘vesicle plus
sphere’ model was required to ﬁt the data recorded at pH 7.4 and pH
5.5, whereas a spherical micelle model incorporating mass fractals was
required to ﬁt the SAXS data obtained at pH 3.0 (Table S1†).
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4811–4821 | 4815
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combined with an additional population of mass fractals
(population 3 in Table S1†), as recently reported byMable et al.43
For this model, it was assumed that the protonated PDPA
chains are located within the micelle corona along with the
permanently hydrophilic PGMA and PMPC blocks. Thus, only
the rhodamine-labeled PHPMA-rich block forms the nano-
particle cores.
The Rg and xsol were xed parameters for tting the SAXS
pattern recorded at pH 3.0. It is physically reasonable to use the
same Rg value as that required to t the SAXS patterns observed
at pH 7.4 and 5.5 because the PDPA block is actually shorter (DP
¼ 52) than the PGMA and PMPC blocks (DP ¼ 58 and 60,
respectively). Consequently, when the PDPA block becomes
hydrophilic, the coronal chain density increases, but the corona
thickness remains essentially constant. Mable et al.42 reported
that, for vesicle membranes comprising PHPMA chains with
a xed DP plus PBzMA chains of variable DP, the corresponding
SAXS patterns are best tted using a constant xsol value, rather
than allowing xsol to vary. Thus, it is reasonable to use the same
xsol value as that used for tting the SAXS patterns recorded at
pH 7.4 and 5.5.
Similarly, the cores of the pseudo-spherical nanoparticles
formed at pH 3.0 comprise mainly HPMA units, with just one
unit of GlyMA and rhodamine B piperazine per copolymer
chain. Warren et al. used a similar solvent volume fraction
parameter for the SAXS analysis of PHPMA-based vesicles.57
To summarize, an Rg of 2.4 nm and an xsol of 0.40 were used as
xed parameters for tting the SAXS pattern recorded at pH
3.0. The mean micelle diameter Ds obtained from SAXS anal-
ysis [Ds ¼ 2(Rs + 2Rg) ¼ 25 nm] was consistent with DLS and
TEM results (Table 1). A reduction in the micelle core diam-
eter at pH 3.0 (15.0 nm, Table S1†) compared to the mean
diameter of the globules within the framboidal vesicle
membranes at pH 5.5 (16.2 nm, Table S1†) supports the sug-
gested location of the PDPA chains within the micelle corona
at the former pH. The mass fractal dimension d obtained from
SAXS analysis is relatively low (d  1.76, Table S1†), indicating
that the framboidal vesicles disintegrate to form weakly-
interacting spherical micelles as suggested by TEM (Fig. 4c)
and DLS studies.
The aqueous vesicle dispersions produced via the ‘sterile
synthesis’ protocol were assessed for the presence of bacteria.
Bioburden analysis conrmed that these dispersions were
indeed sterile aer sample inoculation in liquid media (no
turbidity) and on agar plates (no colony growth), see Fig. S3.† In
contrast, aqueous vesicle dispersions prepared using a standard
non-sterile protocol tested for positive for the presence of
bacteria, as judged by the greater turbidity of the bacterial broth
and also colony growth on agar plates (Fig. S3†). Sterile aqueous
dispersions were then evaluated for their biocompatibility via
MTT assays using human dermal broblast (HDF) cells for 24 h
(Fig. S4†). No detrimental eﬀect on the HDF cells (>95%
viability) was observed for copolymer concentrations ranging
from 0.25 to 5.00% w/v when compared to a control group. Such
concentrations were signicantly greater than the 0.1% w/v
copolymer concentration used for the cell uptake experiments
(Fig. S4†). These cell viability data conrmed that highly
biocompatible vesicles were obtained using the sterile PISA
synthesis protocol, which were suitable for subsequent cell
uptake studies.
Cell uptake experiments
Cell uptake experiments were performed using non-cancerous
HDF cells, the human breast cancer cell line MCF-7 and the
TN breast cancer cell line MDA-MB-231 in conjunction with the
framboidal G58–(H300-stat-ERh1)–D48 and (97 G58 + 3M60)–(H300-
stat-ERh1)–D52 triblock copolymer vesicles. Flow cytometry
studies conrmed that all three cell types express SR-B1 and/or
CD-36 scavenger receptors (see Fig. S5†), which are known to
facilitate uptake of phosphorylcholine-decorated nano-
particles.50,51 More specically, both HDFs and MCF-7 over-
express CD-36, whereas the MDA-MB-231 cells express minimal
levels of this receptor. Conversely, MDA-MB-231 cells over-
express SR-B1 but both HDFs and MCF-7 exhibit negligible
expression of SR-B1.
Experiments performed over 12 h using the G58–(H300-stat-
ERh1)–D48 framboidal vesicles revealed that their uptake was
negligible for all three cell lines (Fig. 5). This is attributed to
their all-hydroxyl surface functionality. However, uorescence
microscopy studies using the (97 G58 + 3 M60)–(H300-stat-ERh1)–
D52 triblock copolymer vesicles conducted in parallel over the
same time scale revealed that MDA-MB-231 cells (which over-
express SR-B1 receptors) were internalized but uptake of these
nanoparticles was negligible for both the MCF-7 and HDF cells
(Fig. 5).
This was conrmed by ow cytometry experiments (see
Fig. S6†). This suggests that the PMPC targeting ligand is
essential for the rapid intracellular uptake of framboidal vesi-
cles by cells that overexpress SR-B1 receptors. Moreover, these
studies conrmed that some internalized vesicles were retained
Table 1 Summary of hydrodynamic diameter, DLS polydispersity and zeta potentials (recorded at pH 7.4, pH 5.5 and pH 3.0) for the (97 G58 + 3
M60)–(H300-stat-ERh1) precursor vesicles and (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 framboidal vesicles prepared via aqueous PISA under
sterile conditions. The mean globule diameter for the latter vesicles determined by TEM and SAXS is also indicated
Copolymer composition
Hydrodynamic diameter (nm) and DLS
polydispersity Zeta potential (mV)
Globule diameter
(nm)
pH 7.4 pH 5.5 pH 3.0 pH 7.4 pH 5.5 pH 3.0 TEM SAXS
322 (0.10) 365 (0.25) 318 (0.09) 27 1.2 +1.7 N/A N/A
322 (0.13) 329 (0.14) 39 (0.18) 2.3 +12 +32 28  8 28
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at the periphery of the nuclear region in the endolysosomal
compartments while others are located within the nuclear
region (see inset shown in Fig. 5c).
To investigate this observation further, internalized
rhodamine-labeled nanoparticles (red) were co-localized with
the MDA-MB-231 cell nuclei, which were stained blue using
Hoechst 33342. Co-staining within the nuclear region was
conrmed (see pink regions in Fig. S7†), indicating that
a signicant proportion of the copolymer escapes from the
endocytic pathway and reaches the cell nuclei, as expected for
virus-mimicking nanoparticles (Fig. S7†).
To further evaluate the ability of these new virus-mimicking
framboidal vesicles to target the nuclear region, electroporation
was used to load pEGFP DNA within (97 G58 + 3 M60)–(H300-stat-
ERh1)–D52 framboidal vesicles (Fig. 6a). Gel shi assay analysis
indicated that 87% of supercoiled pEGFP was encapsulated
within the framboidal vesicles, which corresponds to approxi-
mately 70% of the total amount of plasmid DNA (see Fig. S8†).
Then cell uptake experiments were performed for 16 h using
MDA-MB-231 cells. Delivery of this plasmid nucleic acid payload
to the cell nuclei was conrmed via expression of uorescent
EGFP within the cells (see Fig. 6b and S9†). This conrmed the
endolysosomal release of fully-functional biomolecules (in this
case, DNA) with no signicant toxicity (Fig. S4†). It is perhaps
worth emphasizing that the framboidal vesicle morphology
remained intact aer electroporation, as conrmed by TEM
studies (see Fig. S10†).
Herein, we utilize a schematic cartoon to discuss the in situ
acidication of (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 framboi-
dal vesicles during their endocytic internalization by MDA-MB-
231 breast cancer cells (Fig. 7a). At physiological pH, the fram-
boidal vesicle morphology is stable (Fig. 4a and 7b, and Table 1).
At the relevant endosomal pH (pH 5.5 to pH 6.5), the hydro-
phobic PDPA chains become partially protonated so the vesicles
begin to swell but remain intact (Fig. 4b and 7c, and Table 1).
However, further reduction in solution pH (such as that typi-
cally found within the lysosomal compartment) leads to rapid
vesicle dissociation (Fig. 4c and 7d, and Table 1).
This is because the pendent tertiary amine groups on the
block become fully protonated and, as a consequence, the PDPA
hydrophobic chains become hydrophilic.58,59 The copolymer
chains do not become molecularly dissolved but instead form
weakly-interacting cationic micelles withmass fractal character.
These micelles comprise a mixture of PGMA, PMPC and PDPA
chains in the coronal layer and HPMA-rich cores.
Discussion
Many cancer cell types use scavenger receptors in addition to de
novo lipogenesis to acquire lipids, fatty acids etc. Subsequent
lipolysis provides additional energy that fuels their growth.60–62
Fig. 5 Comparison of the extent of uptake of two types of framboidal triblock copolymer vesicles by HDFs, MCF-7 and MDA-MB-231 cells.
Fluorescence and merged (optical plus ﬂuorescence) micrographs recorded for G58–(H300-stat-ERh1)–D48 (left) and (97 G58 + 3 M60)–(H300-
stat-ERh1)–D52 (right) vesicles after 12 h exposure to (a) HDFs, (b) MCF 7 and (c) MDA-MB-231. Inset: higher magniﬁcation merged image
conﬁrming that some internalized vesicles are retained at the periphery of the nuclear region in the endolysosomal compartments while others
are located within the nuclear region.
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4811–4821 | 4817
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Thus cancer cells overexpress scavenger receptors at their
surface to maximize their lipid uptake.61
Both SR-B1 and CD-36 scavenger receptors are highly
expressed by many rapidly-growing malignant tumors,
including breast cancer.60,62,63 In view of the high metabolic
activity that is linked to the overexpression of SR-B1/CD-36 by
cancer cells, such receptors were considered to be attractive
targets for developing selective cancer therapies based on the
new virus-mimicking framboidal vesicles reported herein. More
specically, TN breast cancer cells (i.e. ER-negative, PR-negative
and those for which HER2/Neu is not overexpressed) lack suit-
able targeted therapies24 and both overexpress SR-B1 and
underexpress CD-36.25 Not surprisingly, such aggressive malig-
nant tumors are usually associated with very poor prognoses.
Interestingly, the same pattern of expression (i.e. relatively high
levels of SR-B1 and low levels of CD-36 in TN cell line MDA-MB-
231) was observed in our study. Furthermore, de Gonzalo-Calvo
and collaborators25 reported that such behaviour led more
eﬀective accumulation of intratumoral lipids in such tumors,
which suggests that targeting the SR-B1 receptor could provide
an alternative therapy for TN breast cancers.
However, such targeting is non-trivial, as scavenger receptors
are notoriously promiscuous in their aﬃnity for many
ligands.64,65 Nevertheless, it is increasingly apparent that
members of the Flaviviridae family of viruses (i.e. the Hepatitis
C virus66 and, more recently, the Dengue virus15) can hijack the
SR-B1 cell entry pathway to facilitate eﬃcient infection with
high cell specicity. In particular, the relatively smooth surface
of the Dengue virus observed in mosquitos at 28 C acquires
distinctly framboidal character in its human host at 37 C.13
This thermally-induced morphological transition is believed to
be strongly associated with the mechanism of infection, most
likely because it exposes critical domains.13,14 The full entry path
of this virus has not yet been elucidated, but it is known that the
SR-B1 scavenger receptor plays an important role.15 The wholly
synthetic Dengue virus-mimicking framboidal vesicles
described herein express phosphorylcholine-functionalized
PMPC chains at their surface in order to target SR-B1/CD-36
receptors. Interestingly, such framboidal vesicles proved to be
very eﬀective for targeting human breast cancer cells that
overexpress SR-B1 receptors along with very low CD-36 receptor
expression. In contrast, essentially no uptake was observed
within 12 h for (i) non-cancerous HDF cells expressing low levels
of such receptors and (ii) for breast cancer cells that do not
express the SR-B1 receptor. Particle diameters of 20–30 nm have
been reported to be optimal for CD36 and SRB-1 receptors when
targeting ‘natural’ endogenous particles within the cell that are
involved in the transport and metabolism of cholesterol,
phospholipids and triglycerides.27,28 Such receptors are also
involved in the uptake of many exogenous particles greater than
20–30 nm diameter,69 such as the Dengue virus.15 Moreover,
small surface domains of PMPC ligand on smooth vesicles of up
to 400 nm diameter are known to enhance their intracellular
uptake.70 However, to the best of our knowledge the use of
framboidal synthetic vesicles is novel and the unexpected
selectivity observed for SRB1 is also new. Interestingly, the
Dengue virus acquires ‘framboidal’ character as part of its
infection strategy, which is known to involve the SRB1 receptor.
Moreover, the dimensions of this virus exceeds that of the
‘natural’ targets for this receptor. Thus such behavior mimics
the eﬃcient targeting of SR-B1 displayed by the Dengue virus.
This was somewhat unexpected, because it is well-known that
‘smooth’ (i.e. non-framboidal) phosphorylcholine-
functionalized liposomes40 or vesicles41 are avidly taken up by
a wide range of cell lines that express type B scavenger recep-
tors. In the latter study, receptor blocking experiments
conrmed that both SR-B1 and CD36 are involved in the uptake
of PMPC-decorated vesicles by both normal and cancer cell
lines. Thus it seems likely that the distinctive framboidal vesicle
morphology may facilitate more eﬃcient targeting of cancer
cells that express SR-B1. In this context, it is perhaps noteworthy
that nanodomains protruding from synthetic block copolymer
vesicles have also been found to perform better than conven-
tional ‘smooth’ vesicles. The former exhibit extended blood
circulation times and faster cellular uptake than the latter, even
when the former vesicles are considerably larger.7 Physical
models also suggest that protruding nanoscale surface domains
on nanoparticles can induce suﬃcient membrane deformation
to promote their more eﬃcient engulfment.16–18 Thus, fram-
boidal surface character could be advantageous not only for
Fig. 6 Eﬀective intracellular delivery of EGFP plasmid DNA within
MDA-MB-231 cells using (97 G58 + 3 M60)–(H300-stat-ERh1)–D52
framboidal vesicles. (a) Schematic representation of the use of elec-
troporation to load these triblock copolymer vesicles with EGFP DNA.
For this experiment, 10 mL of a 0.50 g L1 aqueous solution of
plasmid DNA (5.0 mg) was added via micropipet to 1.0 mL of a 0.5 
103 g L1 aqueous dispersion of copolymer vesicles in PBS within
each sterile electroporation cuvette. (b) Fluorescence micrograph
recorded for MDA-MB-231 breast cancer cells treated with EGFP
plasmid-loaded nanoparticles (N.B. in this experiment, green indicates
successful EGFP expression while red shows the location of the
rhodamine-labeled vesicles).
4818 | Chem. Sci., 2019, 10, 4811–4821 This journal is © The Royal Society of Chemistry 2019
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targeting cancer cells that express SR-B1 but also for enhanced
endocytosis. Furthermore, unlike the equivalent smooth nano-
particles, Hu and co-workers7 demonstrated that nanoparticles
comprising protruding nanodomains could bypass endolyso-
somal compartments and eﬃciently deliver drugs to the nuclear
region.7 However, the precise mechanism of endocytosis and
release remains unclear for such systems. Nevertheless, the
Dengue virus similarly utilizes nanoscale surface nanodomains
along with critical pH-dependent activation to ensure eﬃcient
transport within the endocytic organelles and exit at the peri-
nuclear area.71 The surface domains formed by the E glycopro-
tein become disentangled at pH 5.5, exposing an ‘open’
conformation that enables eﬀective fusion with the endosomal
membrane.22,23 Like the Dengue virus, a subtle change in
morphology (and surface charge) is observed for these
framboidal vesicles as the tertiary amine groups on the PDPA
chains become partially protonated at around pH 5.5. It is well-
known67,68 that polymeric transfection reagents such as poly(-
ethylene imine) have primary, secondary and tertiary amines
with pKa values covering the whole physiological pH range, thus
enabling buﬀering capacity within the endosomes and high
levels of gene transfer to the cell nucleus. The high buﬀering
capacity of such synthetic polyamines enhances proton pump-
ing into the endosomes, which also increases the inux of
chloride ions to maintain charge neutrality.67 As a result, the
higher ionic strength within the endosomes causes osmotic
swelling, temporary rupture of the endosomal membrane and
hence release of cargo at the periphery of the nuclear region.67,68
We hypothesize that the PDPA block similarly buﬀers acidi-
cation of the endosomes and, although part of the cargo is
Fig. 7 (a) Schematic cartoon depicting the likely eﬀect of intracellular acidiﬁcation of (97 G58 + 3 M60)–(H300-stat-ERh1)–D52 nanoparticles
during their endocytic internalization by MDA-MB-231 triple-negative breast cancer cells. After internalization by these cells, the vesicles are
expected to remain intact at physiological pH, see TEM image (b). As the pH drops below pH 6.2 in the early endosomes, the PDPA block
becomes partially protonated, see chemical structure shown in (e), and thus less hydrophobic, which leads to vesicle swelling (and perhaps
greater porosity). At pH 5.5, the vesicle membrane becomes increasingly porous as the PDPA block loses its hydrophobic character, see TEM
image (c). The gradual increase in cationic charge density is believed to trigger a ‘proton sponge’ eﬀect64 as water swells the late endosomes to
counteract the increase in ionic strength. This should cause temporary rupture of the endosomes and release of its cargo into the nuclear
region.64,65 In the lysosomes the local pH is 3.0. The PDPA block is expected to be fully protonated at this pH, leading to the formation of weakly-
interacting cationic spherical micelles, see TEM image (d). These pH-inducedmorphological transitions can be studied by TEM for dilute aqueous
vesicle dispersions dried at (b) pH 7.4, (c) pH 5.5 and (d) pH 3.0. (e) Chemical structure of the PDPA block when fully deprotonated above pH 6.2
and when full protonated below pH 6.2 (this pH approximately corresponds to the pKa of the PDPA block, although this parameter is dependent
on the ionic strength).
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4811–4821 | 4819
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retained within the endolysosomes, suﬃcient plasmid DNA can
be delivered to the nuclear region to enable EGFP expression by
the targeted cells.
Conclusions
Herein we report the eﬃcient synthesis of rhodamine-labeled
pH-responsive framboidal triblock copolymer vesicles in
sterile aqueousmedia. TEM and SAXS studies indicate that such
vesicles comprise surface globules of approximately 28 nm and
their pH-responsive character enables the intracellular release
of biologically-relevant cargoes (e.g. plasmid DNA) within the
nuclear region, suggesting release via an endocytic pathway. In
vitro studies conrm that introducing a phosphorylcholine-
based targeting ligand for the SR-B1 receptor is essential for
the selective intracellular uptake by MDA-MB-231 breast cancer
cells compared to non-cancerous HDF cells, because the former
cells overexpress such surface receptors. In summary, these new
synthetic vectors suggest new therapeutic approaches for
treating TN breast cancer, for which existing treatments oﬀer
only relatively poor prognoses.
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